- Investing.com
Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases in the United States. The company operates in two segments, Surgical Glaucoma and Dry Eye. It offers OMNI, a surgical system family of products, such as OMNI Ergo for the catheterization and transluminal viscodilation of Schlemm’s canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and OMNI EDGE, an implant-free and minimally invasive glaucoma surgery technology. The company also provides SION, a bladeless and manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork; and TearCare system, a proprietary, interventional, dry eye device designed to melt and facilitate the comprehensive removal of meibomian gland obstructions and restore gland functionality and healthy oil production for adult patients with evaporative dry eye disease due to meibomian gland disease when used in conjunction with manual expression of the meibomian glands for ophthalmologists and optometrists. It serves hospitals, medical centers, and eyecare professionals through sales representatives and distributors. The company was incorporated in 2010 and is headquartered in Menlo Park, California.
तुलना करने के लिए मीट्रिक्स | SGHT | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधSGHTपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −5.6x | −5.5x | −0.5x | |
PEG अनुपात | −0.20 | 0.06 | 0.00 | |
क़ीमत/बुक | 3.4x | 4.2x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 2.8x | 3.0x | 3.2x | |
अपसाइड (विश्लेषक लक्ष्य) | 107.8% | 41.0% | 50.1% | |
उचित मूल्य अपसाइड | अनलॉक करें | 10.7% | 6.5% | अनलॉक करें |